Reltecimod TFA, Antimicrobial Peptide (AMP) (CAT#: BMWJ-0826-WJ64)
Product Quick View
Reltecimod (AB-103) TFA is a T-cell-specific surface glycoprotein CD28 (TP44) antagonist. Reltecimod TFA has beneficial effects against different bacterial infections, their exotoxins and endotoxins, and ionizing radiation. Reltecimod TFA modulates the inflammatory response by targeting and attenuating the critical CD28/B7-2 co-stimulatory pathway, without inhibiting it. Reltecimod TFA can be used to research necrotizing soft-tissue infections (NSTIs).
| Overview | |
|---|---|
| Synonyms | Reltecimod TFA; AB-103 TFA; Reltecimod; AB-103; AB103; TREM-1 antagonist peptide |
| Source | Not specified |
| Molecular Weight | 1037.19 (free base) |
| Sequence | {d-Ala}-Ser-Pro-Met-Leu-Val-Ala-Tyr-Asp-{d-Ala} |
| Sequence Shortening | {d-Ala}-SPMLVAYD-{d-Ala} |
| Activity | Gram-positive bacteria; Gram-negative bacteria; Fungi; Virus; Cancer cells; Biofilm; Immunomodulation |
| Physical State | Powder |
| Purity | >98% |
| Storage | The power can be stored at 4°C for 2 years or at -20°C for 3 years. |
For Research Use Only.
Related products
- GE2270A, Antimicrobial Peptide (AMP) (CAT#: BMWJ-0826-WJ103)
- HG2, Antimicrobial Peptide (AMP) (CAT#: BMWJ-0826-WJ434)
- eCATH-1, Antimicrobial Peptide (AMP) (CAT#: BMWJ-0826-WJ393)
- Maximin 39, Antimicrobial Peptide (AMP) (CAT#: BMWJ-0826-WJ502)
- Tur1A, Antimicrobial Peptide (AMP) (CAT#: BMWJ-0826-WJ634)
- C18G, Antimicrobial Peptide (AMP) (CAT#: BMWJ-0826-WJ325)
- LANA peptide, Antimicrobial Peptide (AMP) (CAT#: BMWJ-0826-WJ460)
- Cr-ACP1, Antimicrobial Peptide (AMP) (CAT#: BMWJ-0826-WJ356)
Online Inquiry